Exploring the scope of enhanced gonococcal antimicrobial surveillance programme
Sir, Worldwide, sexually transmitted infections (STIs) tend to cast a major influence on the sexual and reproductive health status and are one of the most common ailments for which health care services are utilized. [1] In fact, more than 1 million people every day acquire STI while on an annual basis, almost 500 million people acquire any of the four major STIs. [1] Although antibiotic resistance has emerged against most of the STIs, it has been anticipated that very soon management of gonorrhea infection will be intractable. [2] Further, reports of resistance of gonorrhea to antibiotics have been observed in 36 nations, including cases of multidrug-resistant gonorrhea (viz., resistance to penicillin, broad spectrum antibiotics, cephalosporins, etc.). [1, 2] The reports of multidrug resistance against gonorrhea is a major public health concern, as a disease which could be cured by taking a single dose of antibiotic, might now result in long-term complications such as infertility, pregnancy complications, and neonatal blindness. [3] This is a serious issue for the policy makers to contend with, as most of the developing nations are already struggling with resource/logistic constraints, poor awareness, stigma, limited contact tracing or case-holding, and shortcomings in screening activities. [1] [2] [3] The primary strategy for reducing the spread of gonorrhea is to ensure early detection and treatment and to extend supportive care to the people. [3] Both of these strategies are quite indispensable as most of the people hesitate to avail health care services, and hence, it becomes imperative to provide effective treatment whenever people come to health centers. [3, 4] To contain the problem, the World Health Organization has implemented the Gonococcal Antimicrobial Surveillance Programme (GASP) to ascertain the trends of spread and emergence of gonorrhea resistance. [3] Further, an enhanced version of the GASP has been initiated in Thailand to obtain an accurate estimate about the number of people with gonococcal infections, their demographic parameters, and type of treatment needed, to eventually enable provision of nondiscriminatory health care. [3] This initiative aims to improve on the existing surveillance system in the country by providing standardized guidelines for testing laboratory specimens, emphasizing on eliciting surplus clinical/demographic/behavioral information, and in altering the treatment strategy depending on the pattern of gonococcal antibiotic resistance. [3] Further, these estimates can be utilized in the assessment of the global trends and to ensure comparison between various nations. [3] [4] [5] Moreover, it has been advocated that any nation which can ascertain and then only provide appropriate therapeutic care can significantly address the problem of gonorrhea. [4, 5] In addition, a simultaneous improvement in the existing STI package of services, better emphasis on behavior alterations and compliance with the treatment guidelines, and ensuring involvement of the community in different stages of the program can play a significant role in enhancing the utility of the services. [1, 3] In conclusion, the strategy of enhanced gonococcal resistance surveillance program can play a crucial role in significantly improving the treatment outcome of gonoccal infections in the coming years.
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Seroprevalence of transfusion-transmissible infections among replacement and voluntary blood donors in a tertiary care hospital
Sir, Blood bank plays a pivotal role in ensuring supply of safe blood as and when required. However, recruitment of healthy blood donors is a challenge that the health industry is facing today. Predominantly, the blood donation is derived from family and friends as replacement donors for the patient.
A retrospective study was carried out in the Department of Blood Bank in a Tertiary Care Hospital in New Delhi from May 2014 to November 2015. All blood donors were screened for transfusion transmitted infections (TTI) such as hepatitis B surface antigen ([HBsAg]; Hepalisa), anti-HIV antibodies (HIV 3 rd generation kit for detection of antibodies to HIV1 and HIV2), anti-hepatitis C virus antibodies ([HCV] MicroELISA 3 rd generation), rapid plasma reagin (RPR) and malarial antigen.
Among 41,657 blood donations, 40,187 (96.4%) were replacement and 1470 (3.52%) were voluntary donors. Predominant donor population was males 41,416 (99.42%). A comparison of the demographic profile of the voluntary and replacement donors have been shown in Table 1 .
Out of total 41,657 donations, 1682 (4.03%) were found to be positive for one of the infectious diseases and the corresponding blood bags were discarded. HBsAg (2.54%) was the most common infection in both voluntary and replacement donors, followed by HCV (1.07%) as shown in Table 2 . Dual positivity for HIV and HBsAg was found in three donors. Only 21 (1.42%) voluntary donors were found to be TTI positive as compared to 1661 (4.13%) replacement donors.
A comparison of the seroprevalence of TTIs among voluntary and replacement donors have been shown in Table 2 .
Our study correlated with the existing studies with overall seroprevalence for HIV, HBsAg, HCV, and syphilis as 4.03% (1680 cases). [1, 2] Seroprevalence of HBsAg and HCV was 2.54% and 1.07% and was again comparable to other studies. [3] However, a significant difference between the seroprevalence of HBsAg and HCV among replacement (2.61% and 1.09%) and voluntary donors (0.75% and 0.34%) is noted as compared to other studies. HBV (62.9%) was most common infection according to our study followed by HCV (26.4%) and HIV (8.2%). The prevalence of coinfection in our study was very low (0.01%) as compared to other studies where the prevalence of coinfection was high. [4] The RPR reactivity for syphilis in our study was 0.09% which was comparable to other studies. [5] In this study, HIV and syphilis seroprevalence showed no significant difference between voluntary and replacement donors.
Seroprevalence of TTI among the donors leads to discard and wastage of a large volume of blood. The overall lower prevalence of TTI among voluntary
